• ROTIGOTINE CHEMBL1303 FDA Approved

    Alternate Names:

    Rotigotine
    SPM-962
    Neupro
    1-NAPHTHALENOL, 5,6,7,8-TETRAHYDRO-6-(PROPYL(2-(2-THIENYL)ETHYL)AMINO)-, (6R)-
    (6R)-5,6,7,8-TETRAHYDRO-6-[PROPYL[2-(2-THIENYL)ETHYL]AMINO]-1-NAPHTHALENOL
    (+)-5,6,7,8-TETRAHYDRO-6-(PROPYL(2-(2-THIENYL)ETHYL)AMINO)-1-NAPHTHOL
    UNII-5QTR54Z0E1 COMPONENT KFQYTPMOWPVWEJ-MRXNPFEDSA-N
    ZINC5151
    SCHEMBL9405994
    ROTIGOTINE, (+)-
    112835-48-0
    (+)-ROTIGOTINE
    N-0924
    N 0924
    N8FO6Z42IR
    9904975
    UNII-N8FO6Z42IR
    6-[PROPYL-(2-THIOPHEN-2-YL-ETHYL)-AMINO]-5,6,7,8-TETRAHYDRO-NAPHTHALEN-1-OL
    1-NAPHTHALENOL 5 6 7 8-TETRAHYDRO-6-[PROPYL[2-(2-THIENYL)ETHYL]AMINO]- (6S)-
    (6S)-6-{PROPYL[2-(THIOPHEN-2-YL)ETHYL]AMINO}-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL
    (-)-5-HYDROXY-2-[N-N-PROPYL-N-2-(2-THIENYL)ETHYLAMINO]TETRALIN
    A844177
    X7263
    FT-0674467
    RT-012473
    HE415835
    HE296667
    HE061212
    AS04619
    AKOS025311301
    BDBM50054062
    KFQYTPMOWPVWEJ-UHFFFAOYSA-N
    CTK8E7910
    1-NAPHTHALENOL, 5,6,7,8-TETRAHYDRO-6-(PROPYL(2-(2-THIENYL)ETHYL)AMINO)-
    SCHEMBL50425
    2-(N-N-PROPYL-N-2-THIENYLETHYLAMINO)-5-HYDROXYTETRALIN
    L001423
    PUBCHEM16422
    DB05271
    PDSP2_001830
    AC1L1N7C
    AC1Q7ALS
    6-[PROPYL(2-THIOPHEN-2-YLETHYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL
    6-(PROPYL(2-(2-THIENYL)ETHYL)AMINO)-5,6,7,8-TETRAHYDRO-1-NAPHTHALENOL
    ROTIGOTINE TRANSDERMAL PATCH
    92206-54-7
    57537
    ENT-ROTIGOTINE
    PDSP1_001847
    CHEMBL104383
    135650929
    941
    99755-59-6
    (6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol
    CID57537
    12014593
    N 0437, (-)-ISOMER
    ROTIGOTINE (USAN/INN)
    DCL000889
    ROTIGOTINE [USAN:INN]
    (6S)-6-[PROPYL(2-THIOPHEN-2-YLETHYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL
    D05768
    AC-3547
    MOLPORT-005-941-578
    ROTIGOTINE CDS
    CID59227
    CHEBI:358371
    C19H25NOS
    N 0923
    AC1L1QQG
    (-)-(S)-5,6,7,8-TETRAHYDRO-6-(PROPYL(2-(2-THIENYL)ETHYL)AMINO)-1-NAPHTHOL
    SPM-937
    CHEBI:268876
    SPM 962
    SPM-936
    59227
    1-NAPHTHALENOL, 5,6,7,8-TETRAHYDRO-6-(PROPYL (2-(2-THIENYL)ETHYL)AMINO-(6S)-
    NCGC00168748-01
    N-0923
    ROTIGOTINE CDS PATCH
    NEUPRO (TN)
    UNII-87T4T8BO2E
    LS-178435
    4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-N-[5-(4-METHYL-1H-IMIDAZO
    1-NAPHTHALENOL, 5,6,7,8-TETRAHYDRO-6-[PROPYL[2-(2-THIENYL)ETHYL]AMINO]-, (6S)-
    (S)-6-[PROPYL-(2-THIOPHEN-2-YL-ETHYL)-AMINO]-5,6,7,8-TETRAHYDRO-NAPHTHALEN-1-OL
    (6S)-6-(PROPYL-(2-THIOPHEN-2-YLETHYL)AMINO)-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL
    S4274,99755-59-6
    UNII-5QTR54Z0E1 COMPONENT KFQYTPMOWPVWEJ-INIZCTEOSA-N
    C498826
    A846076
    W-5179
    EC-000.2344
    L-1-YL)-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
    RT-015446
    AB0088886
    SC-22242
    HY-75502
    BC677693
    AN-12885
    AJ-08188
    NCGC00168748-02
    SS-4572
    RL06136
    CS-0376
    TOX21_112627_1
    AKOS016340728
    DNC001234
    DNC000500
    DCL000360
    CID644241
    BDBM50123626
    2696AH
    TOX21_112627
    MOLPORT-003-987-089
    KFQYTPMOWPVWEJ-INIZCTEOSA-N
    CTK8E7903
    ZINC4028
    SCHEMBL1088585
    87T4T8BO2E
    ROTIGOTINE (JAN/USAN/INN)
    GTPL941
    NILOTINIB (INN/USAN)
    PUBCHEM16423
    CYCLOPENTYLCYTOSINE
    (S)-5,6,7,8-TETRAHYDRO-6-[PROPYL[2-(2-THIENYL)ETHYL]AMINO]-1-NAPHTHOL
    (S)-5,6,7,8-TETRAHYDRO-6-(PROPYL(2-(2-THIENYL)ETHYL)AMINO)-1-NAPHTHOL
    NEUPROREG
    LEGANTO
    LEGANTOREG
    CAS-99755-59-6
    (S)-6-(PROPYL(2-(THIOPHEN-2-YL)ETHYL)AMINO)-5,6,7,8-TETRAHYDRONAPHTHALEN-1-OL
    (2S)-2-[PROPYL-[2-(2-THIENYL)ETHYL]AMINO]TETRALIN-5-OL
    DSSTOX_GSID_46772
    DSSTOX_RID_81893
    DSSTOX_CID_26772
    ROTIGOTINE HYDROCHLORIDE

    Drug Info:

    FDA Approval approved
    Drug Class small molecule
    Drug Indications antiparkinson agent
    Drug Class antiparkinson agent
    Year of Approval 2007
    Drug Categories sulfur compounds
    Drug Categories polycyclic hydrocarbons, aromatic
    Drug Categories polycyclic compounds
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories organic chemicals
    Drug Categories neurotransmitter agents
    Drug Categories nervous system
    Drug Categories naphthalenes
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories inorganic chemicals
    Drug Categories hypotensive agents
    Drug Categories hydrocarbons, cyclic
    Drug Categories hydrocarbons, aromatic
    Drug Categories hydrocarbons
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories dopamine agonists
    Drug Categories dopamine agents
    Drug Categories cytochrome p-450 cyp3a4 substrates
    Drug Categories cytochrome p-450 cyp2d6 substrates
    Drug Categories cytochrome p-450 cyp2d6 inhibitors
    Drug Categories cytochrome p-450 cyp1a2 substrates
    Drug Categories cytochrome p-450 cyp1a2 inhibitors
    Drug Categories chemical actions and uses
    Drug Categories anti-parkinson drugs
    Drug Categories anti-parkinson agents (dopamine agonist)
    Drug Groups approved
    Drug Type small molecule
    (5 More Sources)